Aquestive Therapeutics Inc. (AQST)
AQST trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.67
-2.91% on the day
Market cap
$586.1M
Small cap
Revenue · 2025
$44.5M
-22.6% on 2024
Net income · 2025
-$83.8M
-188.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AQST on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001398733 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $44.5M |
| Net income | -$83.8M |
| Operating income | -$71.1M |
| Net margin | -188.1% |
| Operating margin | -159.5% |
| Revenue growth | -22.6% |
| Cash | $121.2M |
| Total assets | $160.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 13.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-07-09 |
| Latest annual report | 10-K | 2026-03-04 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 678 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.3% |
| 1 month | -4.3% |
| 3 months | +16.9% |
| Year to date | -28.7% |
| 1 year | -30.9% |
| From 52-week high | -38.5% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NVCT | Nuvectis Pharma Inc. | $18.15 | -7.82% | $591.9M |
| CLYM | Climb Bio Inc. | $10.31 | -4.80% | $592.2M |
| IRWD | Ironwood Pharmaceuticals Inc. | $3.59 | -4.52% | $593.2M |
| CRMD | CorMedix Inc. | $7.39 | -0.94% | $576.0M |
| PHAT | Phathom Pharmaceuticals Inc. | $7.00 | -1.82% | $566.3M |
| SGMT | Sagimet Biosciences Inc. Series A | $7.98 | -9.32% | $562.9M |
| DSGN | Design Therapeutics Inc. | $9.78 | -10.36% | $612.0M |
| OLMA | Olema Pharmaceuticals Inc. | $7.02 | -4.62% | $614.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier